Global AI-Enabled Drug Discovery and Clinical Trials Market Size is valued at USD 883.9 Million in 2024 and is predicted to reach USD 9321.5 Million by the year 2034 at a 26.7 % CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
AI-Enabled Drug Discovery and Clinical Trials are expected to gain promiscuous popularity over the coming years due to a rapid increase in the use of AI worldwide and its increasing scope of application in multiple industry verticals. Artificial intelligence technology is advancing rapidly, and continuous technological advancements are expected to boost AI-Enabled Drug Discovery and Clinical Trials market potential. The increasing digitization of the healthcare industry will also majorly propel AI-Enabled Drug Discovery and Clinical Trials across the world through 2031. Rising research and development activity will also help the AI-Enabled Drug Discovery and Clinical Trials market gain the expected impetus in the global marketplace through 2031.
However, the high costs associated with AI-Enabled Drug Discovery and Clinical Trials are expected to have a negative impact on the global AI-Enabled Drug Discovery and Clinical Trials market growth. The AI-Enabled Drug Discovery and Clinical Trials market experienced an increase in demand in the COVID-19 pandemic to fast track development of vaccines, and this trend set the stage for future market growth and will enhance AI-Enabled Drug Discovery and Clinical Trials market performance over the forecast period.
The AI-Enabled Drug Discovery and Clinical Trials market is segmented on the basis of product and application. Based on the component scope, the market is segmented into solutions and services. By application, the market is segmented into Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, and Biomarker Research. By therapeutic application, the market is segmented into Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorders, Metabolic Diseases, Immunologic Diseases, and Infectious Diseases. By end-users, the market is segmented into Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers.
The incidence of cancer has risen substantially over the past few years, and this has bolstered demand for oncology across the world. Increasing investments in oncology research and development are expected to boost AI-Enabled Drug Discovery and Clinical Trials market potential over the forecast period. The oncology segment is expected to be the most lucrative application segment over the forecast period.
The biopharmaceutical industry has taken notable strides ahead over the past few years, and this trend is rife over the forecast period as well. The rising number of biopharmaceutical companies across the world and increasing investments in research activity coupled with supportive government initiatives are expected to provide highly lucrative opportunities for AI-Enabled Drug Discovery and Clinical Trials market growth through 2031.
Global AI-Enabled Drug Discovery and Clinical Trials market in North America is estimated to dominate the forecast period due to the existence of strong healthcare infrastructure. Increasing investment on R&D activities sponsored by governments in this area is likely to be a major driver through 2030. Increasing adoption of technology in healthcare, favorable reimbursement policies, the surge in chronic diseases, rising incidence of cancers, and increasing demand for better diagnostics and treatment are other factors that are anticipated to propel the AI-Enabled Drug Discovery and Clinical Trials market growth over the forecast period. The United States and Canada are expected to lead the market growth in this region through 2031.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 883.9 Million |
| Revenue Forecast In 2034 | USD 9321.5 Million |
| Growth Rate CAGR | CAGR of 26.7% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Component Scope, By Application, By Therapeutic Application, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Biogas Products Ltd., CNG Services Ltd., Cryon Purr, Envi Tec Biogas AG, ETW Energietechnik GmbH, Future Biogas Ltd., Gasline, Gasrec Ltd, Gazasia Ltd., Green Gas Certification, JV Energe, Magne Gas, MemfoACT, Nordsol, ORBITA, Planet Biogas Global Gm, Schmack Carbotech GmbH, Southern California Gas Compa, VERBIO. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Component Scope-
By Application
By Therapeutic Application
By End-Users
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Enabled Drug Discovery and Clinical Trials Market Snapshot
Chapter 4. Global AI-Enabled Drug Discovery and Clinical Trials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape
4.7. Technology Advancement in Global AI-Enabled Drug Discovery and Clinical Trials Market
Chapter 5. Market Segmentation 1: Component Estimates & Trend Analysis
5.1. Component Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Component:
5.2.1. Solutions
5.2.2. Services
Chapter 6. Market Segmentation 2: Application & Trend Analysis
6.1. Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Data Aggregation and Analysis
6.2.2. Clinical Trials
6.2.3. Drug Design
6.2.4. Drug Characterization
6.2.5. Biomarker Research
Chapter 7. Market Segmentation 3: Therapeutic Application Estimates & Trend Analysis
7.1. Therapeutic Application & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Application:
7.2.1. Oncology
7.2.2. Cardiovascular Diseases
7.2.3. Nervous System Diseases
7.2.4. Respiratory Disorder
7.2.5. Metabolic Diseases
7.2.6. Immunologic Diseases
7.2.7. Infectious Diseases
Chapter 8. Global AI-Enabled Drug Discovery and Clinical Trials Market Segmentation 4: End-Users Estimates & Trend Analysis
8.1. End-Users Analysis & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-Users:
8.2.1. Biopharmaceutical Industry
8.2.2. Contract Research Organizations (CROs)
8.2.3. Academic Institutes and Research Centers
Chapter 9. Global AI-Enabled Drug Discovery and Clinical Trials Market Segmentation 3: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Component, 2021-2034
9.1.2. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.1.3. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.1.4. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.1.5. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, 2021-2034
9.2.2. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.2.3. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.2.4. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by End-Users, 2021-2034
9.2.5. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, 2021-2034
9.3.2. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.3.3. Asia pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.3.4. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by End-Users, 2021-2034
9.3.5. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, 2021-2034
9.4.2. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.4.3. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.4.4. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by End-Users, 2021-2034
9.4.5. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. MEA
9.5.1. MEA revenue Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, (US$ Million) 2021-2034
9.5.2. MEA Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.5.3. MEA Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.5.4. MEA revenue Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5.4.1. South Africa
9.5.4.2. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Accutar Biotechnology Inc.
10.2.2. AiCure
10.2.3. Ardigen
10.2.4. Atomwise Inc.
10.2.5. Benevolent AI
10.2.6. Berg
10.2.7. Berkeley Lights
10.2.8. BioAge Labs
10.2.9. Biovista
10.2.10. C4X Discovery Holdings Plc
10.2.11. Clinithink Ltd
10.2.12. Cloud Pharmaceuticals
10.2.13. Cyclica Inc.
10.2.14. CytoReason
10.2.15. Concerto Health AI.
10.2.16. Deep Genomics Inc.
10.2.17. DeepThink Health Inc.
10.2.18. Envisagenics, Inc.
10.2.19. Exscientia Limited
10.2.20. e-therapeutics plc
10.2.21. GNS Healthcare
10.2.22. Insilico Medicine
10.2.23. Lantern Pharma Inc.
10.2.24. Medable, Inc.
10.2.25. Mind the Byte
10.2.26. NuMedii, Inc
10.2.27. Nuritas, Ltd.
10.2.28. Owkin, Inc.
10.2.29. Recursion Pharmaceuticals, Inc.
10.2.30. Schrödinger, LLC
10.2.31. Symphony Innovation, LLC
10.2.32. TARA Biosystems, Inc.
10.2.33. twoXAR, Incorporated
10.2.34. Verge Analytics, Inc.
10.2.35. Winterlight Labs Inc.
10.2.36. WuXi Nextcode Genomics
10.2.37. XtalPi Inc.
10.2.38. Other Prominent Player